CAS: 1628805-46-8
IDH-305
CAS:1628805-46-8
IDH-305 is an orally available, mutation-selective, and brain-penetrant IDH1 inhibitor targeting the IDH1 (R132) mutation. …
Formula:
C23H22F4N6O2
Purity:
99.13%
Color and Shape:
Solid
Molecular weight:
490.45
Ref: TM-T15550
| 1mg | 56.00 € | ||
| 5mg | 124.00 € | ||
| 10mg | 172.00 € | ||
| 25mg | 344.00 € | ||
| 50mg | 520.00 € | ||
| 1ml*10 (DMSO) | 134.00 € |
Estimated delivery in United States, on Tuesday 9 Jul 2024
![(4R)-4-[(1S)-1-fluoroethyl]-3-(2-{[(1S)-1-[4-methyl-2'-(trifluoromethyl)-[3,4'-bipyridin]-6-yl]ethyl]amino}pyrimidin-4-yl)-1,3-oxazolidin-2-one](https://static.cymitquimica.com/products/AN/thumb/AG00IKMH.jpg)
(4R)-4-[(1S)-1-fluoroethyl]-3-(2-{[(1S)-1-[4-methyl-2'-(trifluoromethyl)-[3,4'-bipyridin]-6-yl]ethyl]amino}pyrimidin-4-yl)-1,3-oxazolidin-2-one
CAS:1628805-46-8
Formula:
C23H22F4N6O2
Purity:
98%
Color and Shape:
Solid
Molecular weight:
490.4534
Ref: AN-AG00IKMH
| 1mg | 146.00 € | ||
| 5mg | 256.00 € | ||
| 10mg | 470.00 € | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Tuesday 9 Jul 2024
IDH 305
CAS:1628805-46-8
IDH 305 is a retinoic acid that is used in the treatment of intrahepatic cholangiocarcinoma …
Formula:
C23H22F4N6O2
Purity:
Min. 95%
Molecular weight:
490.45 g/mol
Ref: 3D-DQC80546
| 1mg | To inquire | ||
| 5mg | To inquire | ||
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Tuesday 20 Aug 2024
